Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
07/2010
07/21/2010EP2207784A1 Luminophores
07/21/2010EP2207540A1 Cyclopropyl aryl amide derivatives and uses thereof
07/21/2010EP1854164B1 Polymer ionic electrolytes
07/21/2010EP1265866B1 Aryl substituted pyridines, pyrimidines, pyrazines and triazines and the use thereof
07/21/2010EP1238977B2 Process for the preparation of a pyridinemethanol compound
07/21/2010EP1143970B1 Pyridine compounds, use and preparation thereof
07/21/2010CN1918126B Ionic UV-A sunscreens and compositions containing them
07/21/2010CN1910152B Process for the manufacture of 2,3-dichloropyridine
07/21/2010CN1826310B Novel aminobenzophenone compounds
07/21/2010CN101784538A Pyridoneamide derivatives as focal adhesion kinase (FAK) inhibitors and their use for the treatment of cancer
07/21/2010CN101784525A Process for the synthesis of diaminopyridine and related compounds
07/21/2010CN101784522A proton acceptor iminium/carbocation-type coupling agents
07/21/2010CN101784515A Pyridinecarboxamide and benzamide derivatives as taar1 ligands
07/21/2010CN101781265A Conjugate of amino acid and pesticide and preparation method thereof and application thereof as pesticide
07/21/2010CN101781260A Nitrogen heterocyclic ring series compound and preparation method thereof
07/21/2010CN101781245A New method for synthesizing substitutional pyridine-3-carboxylic acid and analogue
07/21/2010CN101781244A Preparation method of 4-bromo-N- (pyridine-2-methyl) naphthalene-1-sulfonamide compound
07/21/2010CN101407493B Organic material and use thereof in organic EL device
07/20/2010US7759502 Stilbene derivatives and their use for binding and imaging amyloid plaques
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759369 EP1 receptor antagonists; pain, inflammation, bone disorders, neurodegenerative disorders, renal disorders, immunological disorders; 6-(substituted benzyl)-2-pyridinecarboxylic acid, and corresponding amides, carboxysulfonamides, and tetrazoles, where benzyl is substituted with ether, sulfide, sulfone
07/20/2010US7759367 Pharmaceutical compositions and their uses
07/20/2010US7759043 For resist applications; thermostability, storage stability; color filters
07/20/2010CA2581582C Cyclopropyl piperidine glycine transporter inhibitors
07/20/2010CA2502416C N-sulfonyl-4-methyleneamino-3-hydroxy-2-pyridones as antimicrobial agents
07/20/2010CA2486399C Calcium receptor modulating agents
07/20/2010CA2447865C Novel sulfonic acid derivatives
07/20/2010CA2406266C A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds
07/20/2010CA2335162C Biocidal composition and its use
07/20/2010CA2266908C O2-arylated or o2-glycosylated 1-substituted diazen-1-ium-1,2-diolates and o2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
07/15/2010WO2010080537A1 Gpr120 receptor agonists and uses thereof
07/15/2010WO2010080488A1 Continuous liquid-phase process for the synthesis of diaminopyridines from glutaronitriles
07/15/2010WO2010079498A2 Novel polymorph of sorafenib tosylate
07/15/2010WO2010079497A2 Novel polymorph of atazanavir sulfate
07/15/2010WO2010078906A2 Hydrazides method for production and use thereof as herbicide and insecticide
07/15/2010WO2010057101A3 Compounds useful as hiv blockers
07/15/2010WO2010037244A3 Organic compounds suitable for modulating fragrance compositions
07/15/2010WO2010027113A3 Process for preparing (s)-(-)-felodipine
07/15/2010US20100179326 Benzamide derivative
07/15/2010US20100179199 Ethanamine Compounds and Methods of Using the Same 545
07/15/2010US20100179172 N-phenyl-methanamine derivative and pesticide containing it
07/15/2010US20100179141 Novel jnk inhibitors
07/15/2010US20100179137 Pyridone compound
07/15/2010US20100178246 Technetium- and rhenium-bis(heteroaryl) complexes and methods of use thereof for inhibiting psma
07/15/2010CA2746762A1 Gpr120 receptor agonists and uses thereof
07/14/2010EP2206701A1 Crystalline form of flupirtine ((2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl)-carbamic acid ethyl ester)
07/14/2010EP2206700A1 Crystalline form of flupirtine ((2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl)-carbamic acid ethyl ester)
07/14/2010EP2206699A1 Crystalline form of flupirtine ((2-amino-6-(4-fluoro-benzylamino)-pyridin-3-yl)-carbamic acid ethyl ester)
07/14/2010EP2205565A1 1,3-disubstituted-4-phenyl-1 h-pyridin-2-ones
07/14/2010EP2205564A1 Novel kinase inhibitors
07/14/2010EP2205563A2 Novel histone deacetylase inhibitors
07/14/2010EP2205562A1 1,1,1-trifluoro-2-hydroxy-3-phenylpropane derivatives
07/14/2010EP2205559A1 Renin inhibitors
07/14/2010EP2205548A1 Substituted biphenyl gpr40 modulators
07/14/2010EP2205317A1 Pyridine derivatives for the treatment of amyloid-related diseases
07/14/2010EP1951659B1 Glucagon receptor antagonists, preparation and therapeutic uses
07/14/2010CN101778825A N-heterocyclic compounds useful as inhibitors of janus kinases
07/14/2010CN101778824A Process for producing toluidine compound
07/14/2010CN101778823A Method for separating and purifying alpha-unsaturated amine compound
07/14/2010CN101778822A Amide addition reaction
07/14/2010CN101778625A tableted compositions containing atazanavir
07/14/2010CN101778624A tableted compositions containing atazanavir
07/14/2010CN101775038A Marked cyclofenil derivative and referential compound and midbody thereof, and preparation method and application
07/14/2010CN101775013A Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient
07/14/2010CN101775012A caspase inhibitors and uses thereof
07/14/2010CN101774967A Method for preparing 2, 6-dichloro-5-fluorine nicotinoyl ethyl acetate
07/14/2010CN101774966A Process for producing dihalopyridines
07/14/2010CN101773842A Supported catalyst and preparation method thereof
07/13/2010US7754888 Insecticidal N-substituted (heteroaryl)alkyl sulfilimines
07/13/2010US7754886 N-acylsulfonamide apoptosis promoters
07/13/2010US7754743 Heteroarylcarbamoylbenzene derivatives
07/13/2010US7754741 nonphytotoxic of N-[2-(3-Chloro-5-trifluoromethyl-pyridin-2-yl) ethyl]-2-trifluoromethyl-nicotinamide, used for controlling phytopathogenic fungi selected from Alternaria and Pyrenophora
07/13/2010US7754739 Modulators of CFTR
07/13/2010US7754727 Hypotensive agents; atherosclerosis; congestive heart failure; hypertrophy; cardiomyopathy; diabetic nephropathy; restenosis; cognition activator; Alzheimer's disease; anxiolytic agents
07/13/2010US7754726 Benzamide derivatives as p-38 kinase inhibitors
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/13/2010US7754714 (1S, 2R)-N4-(2-Aminocarbonylcyclopent-1-yl)-5-fluoro-N2-[4-(4-methylpiperazin-1-yl)-3-methylphenyl]-2,4-pyrimidinediamine, having antiproliferative activity, used to inhibit cellular proliferation and to treat proliferate diseases such as cancers
07/13/2010US7754462 increases in the yield and selectivity; can be used as co-solvents to improve the solubility of educts and products
07/13/2010US7754188 Antagonists and/or inverse agonists of the Cannabinoid-1 receptor; useful in treatment of central nervous system disorders, psychological disorders, multiple sclerosis, as antiinflammatory agents
07/13/2010CA2446463C Substituted 2-pyridine-cyclohexane-1,4-diamine derivatives
07/13/2010CA2427837C Radioactive member for use in brachytherapy and method of making
07/08/2010WO2010077992A1 Aminopyridine and carboxypyridine compounds as phosphodiesterase 10 inhibitors
07/08/2010WO2010077798A2 Stereoselective synthesis of piperidine derivatives
07/08/2010WO2010077734A2 Novel antiviral compounds, compositions, and methods of use
07/08/2010WO2010077686A1 Isoindolinone and related analogs as sirtuin modulators
07/08/2010WO2010076525A1 Derivatives of 2-pyridin-2-yl-pyrazol-3(2h)-one, preparation and therapeutic use thereof
07/08/2010WO2010076474A1 Method for preparing activated esters
07/08/2010WO2010076034A1 Toluidine sulfonamides and their use as-inhibitors
07/08/2010WO2010076033A1 Toluidine sulfonamides and their use
07/08/2010WO2010075869A1 Toluidine sulfonamides and their use
07/08/2010WO2010056527A3 B-biphenyl sulfonamide compounds as ion channel modulators
07/08/2010WO2010048170A3 Fluorination of aromatic ring systems
07/08/2010WO2010037054A3 Heteroaryl antagonists of prostaglandin d2 receptors
07/08/2010WO2009141290A3 Substituted pyridin-4-ylmethyl sulfonamides
07/08/2010US20100174090 Methods of preparing primary, secondary and tertiary carbinamine compounds in the presence of ammonia
07/08/2010US20100174089 Heteroaryl aryl ethers
07/08/2010US20100174075 Use of nitric oxide-releasing statins in the treatment of pulmonary arterial hypertension
07/08/2010US20100173955 4-substituted phenoxyphenylacetic acid derivatives
07/08/2010US20100173953 4-[4-(amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide monohydrate
07/08/2010US20100173952 Metalloprotein inhibitors
1 ... 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 ... 633